APA (7th ed.) Citation

N, L., R, X., R, H., B, L., B, W., & Q, G. (2021). Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press.

Chicago Style (17th ed.) Citation

N, Li, Xiong R, He R, Liu B, Wang B, and Geng Q. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2021.

MLA (8th ed.) Citation

N, Li, et al. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2021.